Premium
Acute ST Elevation Myocardial Infarction during Intravenous Immunoglobulin Infusion
Author(s) -
BARSHESHET ALON,
MARAI IBRAHIM,
APPEL SHMULIK,
ZIMLICHMAN EYAL
Publication year - 2007
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1196/annals.1423.033
Subject(s) - medicine , myocardial infarction , cardiology , intravenous infusions , antibody , immunology
: Intravenous immunoglobulin (IVIG) preparations are increasingly being used in the treatment of autoimmune disorders. This treatment is regarded as generally safe, and most of the adverse effects associated with IVIG administration are mild and transient. This paper reports a 72‐year‐old patient with known ischemic heart disease admitted for a Guillain–Barré syndrome variant, who developed acute ST elevation myocardial infarction (MI) during the first hours of IVIG infusion. The literature on acute MI during IVIG treatment is reviewed. Evaluation of each patient for cardiovascular risk prior to IVIG treatment is recommended as is the assessment of risk versus benefit. If IVIG is prescribed, we propose close monitoring and slow infusion rate.